These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 18957000)

  • 1. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.
    Bream-Rouwenhorst HR; Hobbs RA
    Pharmacotherapy; 2008 Nov; 28(11):1401-7. PubMed ID: 18957000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up.
    Mattioli AV; Bonetti L; Sternieri S; Mattioli G
    Ital Heart J; 2000 Jan; 1(1):39-42. PubMed ID: 10868921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
    Papalambros E; Sigala F; Travlou A; Bastounis E; Mirilas P
    J Am Coll Surg; 2004 Jul; 199(1):69-77. PubMed ID: 15217633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis.
    Randi ML; Tezza F; Scapin M; Duner E; Scarparo P; Scandellari R; Fabris F
    Acta Haematol; 2010; 123(3):140-5. PubMed ID: 20134155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia, a prothrombotic disease.
    Levy JH; Hursting MJ
    Hematol Oncol Clin North Am; 2007 Feb; 21(1):65-88. PubMed ID: 17258119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
    Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
    Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies.
    Pouplard C; May MA; Regina S; Marchand M; Fusciardi J; Gruel Y
    Br J Haematol; 2005 Mar; 128(6):837-41. PubMed ID: 15755289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic events in patients with antiplatelet factor 4/heparin antibodies.
    Mattioli AV; Bonetti L; Carletti U; Ambrosio G; Mattioli G
    Heart; 2009 Aug; 95(16):1350-4. PubMed ID: 19482851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.
    Warkentin TE; Roberts RS; Hirsh J; Kelton JG
    Arch Intern Med; 2003 Nov; 163(20):2518-24. PubMed ID: 14609790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia.
    Levy JH; Tanaka KA; Hursting MJ
    Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients.
    Chang JJ; Parikh CR
    Semin Dial; 2006; 19(4):297-304. PubMed ID: 16893407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the heparin-induced thrombocytopenia syndrome.
    Warkentin TE
    Semin Thromb Hemost; 2004 Jun; 30(3):273-83. PubMed ID: 15282649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases.
    Refaai MA; Van Cott EM; Laposata M
    Am J Clin Pathol; 2003 Apr; 119(4):497-504. PubMed ID: 12710122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
    Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
    Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia with thrombotic complications.
    Aburahma AF; Malik FS; Boland JP
    W V Med J; 1992 Mar; 88(3):95-100. PubMed ID: 1574877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
    Lobo B; Finch C; Howard A; Minhas S
    Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-induced thrombocytopenia: recent experience in a large teaching hospital.
    Sturtevant JM; Pillans PI; Mackenzie F; Gibbs HH
    Intern Med J; 2006 Jul; 36(7):431-6. PubMed ID: 16780449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia.
    Warkentin TE
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):589-607, v. PubMed ID: 17666280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The approach to heparin-induced thrombocytopenia.
    Linkins LA; Warkentin TE
    Semin Respir Crit Care Med; 2008 Feb; 29(1):66-74. PubMed ID: 18302088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study.
    Gettings EM; Brush KA; Van Cott EM; Hurford WE
    Crit Care; 2006; 10(6):R161. PubMed ID: 17109753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.